<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02181205</url>
  </required_header>
  <id_info>
    <org_study_id>14-024</org_study_id>
    <nct_id>NCT02181205</nct_id>
  </id_info>
  <brief_title>Sphenopalatine Ganglion Block for Post-Dural Puncture Headache</brief_title>
  <official_title>Sphenopalatine Ganglion Block for Treatment of Postdural Puncture Headache: A Prospective Randomized Double Blind Placebo Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are attempting to determine a less invasive method of treatment for
      postdural puncture headaches that can occur after regional anesthesia. The investigators will
      be evaluating the relief of headache with those subjects receiving treatment with a
      sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of
      epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with
      post study treatment versus placebo, and potential side effects of those patients receiving
      study therapy as well as epidural blood patch.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    no eligible participant , technical difficulty, feasiblity
  </why_stopped>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">December 31, 2016</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>verbal pain score</measure>
    <time_frame>1 hour</time_frame>
    <description>a reduction in headache verbal pain score by 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>epidural blood patch</measure>
    <time_frame>7 days</time_frame>
    <description>evaluating the decrease in the necessity of an epidural blood patch to treat the postdural puncture headache</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>1 hour</time_frame>
    <description>patient satisfaction with headache pain relief at 1 hour post treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>30 minutes</time_frame>
    <description>verbal pain score 30 minutes post study treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>7 days</time_frame>
    <description>verbal pain score 7 days post study treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Postdural Puncture Headache</condition>
  <condition>Sphenopalatine Ganglion Block</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sphenopalatine ganglion block performed with normal saline as the placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sphenopalatine ganglion block performed with bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <arm_group_label>bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists assigned class I-III

          -  age &gt;/= 18 years

          -  experiencing a postdural puncture headache within 7 days of neuraxial analgesia rated
             &gt;3/10 pain score

        Exclusion Criteria:

          -  allergy to study medications &lt;18 years of age pain score on presentation &lt;/=3/10 for
             headache
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter H Pan, MD, MSEE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest School of Medicine-Anesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novant Health Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2014</study_first_submitted>
  <study_first_submitted_qc>July 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2014</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Ganglion Cysts</mesh_term>
    <mesh_term>Synovial Cyst</mesh_term>
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

